Growth Metrics

Standard Biotools (LAB) Non-Current Deferred Tax Liability (2016 - 2025)

Standard Biotools (LAB) has disclosed Non-Current Deferred Tax Liability for 12 consecutive years, with $13.9 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 4.09% to $13.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Dec 2025, down 4.09% year-over-year, with the annual reading at $13.9 million for FY2025, 4.09% down from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $13.9 million at Standard Biotools, up from $1.1 million in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $16.9 million in Q4 2021, with the low at $620000.0 in Q3 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $4.1 million, with a median of $1.1 million recorded in 2022.
  • The sharpest move saw Non-Current Deferred Tax Liability plummeted 93.75% in 2022, then skyrocketed 1629.01% in 2024.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $16.9 million in 2021, then tumbled by 93.75% to $1.1 million in 2022, then decreased by 20.28% to $841000.0 in 2023, then surged by 1629.01% to $14.5 million in 2024, then decreased by 4.09% to $13.9 million in 2025.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $13.9 million, $1.1 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.